Furthermore, blasts from AML#4, characterized by a significant percentage of the rare CD38−CD34+ population, were relevant to demonstrate that CAR.CD123-NK cells were able to reduce the percentage of CD123+ cells in in vitro culture (Fig. 4F). This evidence concerns the gene IL3RA and acute myeloid leukemia.